Synaptive Medical Receives FDA 510(k) Clearance for Near-Infrared Fluorescence Visualization, Expanding Application of Existing Robotic Exoscope
March 27, 2024 10:00 ET
|
Synaptive Medical
Near-Infrared fluorescence now available on Modus X robotic exoscope, complementing system’s existing advanced fluorescence capabilities New Infrared fluorescence enables the use of Modus X for...
Synaptive Medical Welcomes Chris Marrus as New Chief Commercial Officer
February 29, 2024 10:00 ET
|
Synaptive Medical
New position of Chief Commercial Officer established to drive sales and growth for Synaptive Chris Marrus brings extensive experience in innovative med tech to Synaptive having held senior leadership...
Synaptive Medical Announces Timothy J. Scannell as New Chair of Board of Directors
August 10, 2023 15:05 ET
|
Synaptive Medical
TORONTO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Synaptive Medical, a global medical device and technology company solving surgical, imaging and data challenges, is pleased to announce the appointment of...
Synaptive Medical Welcomes Provincial Investment to Expand Manufacturing and R&D Activities
August 02, 2023 13:49 ET
|
Synaptive Medical
TORONTO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Synaptive Medical has received $900,000 in support from the Ontario government through the Ontario Together Fund. This funding will support Synaptive...
Synaptive Announces U.S. and Canadian Availability of Next-Generation Robotic-Exoscope, Modus X
March 22, 2023 10:00 ET
|
Synaptive Medical
Synaptive’s previous generation robotic exoscope has been clinically validated over thousands of surgical procedures. It enables surgeons to perform minimally invasive approaches and offers better...
Synaptive Announces a $40 Million Investment from Export Development Canada (EDC) to Accelerate Surgical, Imaging and Data Technologies
March 13, 2023 10:17 ET
|
Synaptive Medical
$40 million investment to develop and expand access to Canadian-made surgical robotics, MRI, and data platforms for medical imaging and operating rooms.Synaptive technology has been installed in 120...
Synaptive Medical Inc. Awarded Inaugural INOVAIT Focus Fund Investments to Fund MRI Project
March 06, 2023 10:17 ET
|
Synaptive Medical
TORONTO, March 06, 2023 (GLOBE NEWSWIRE) -- Synaptive Medical Inc., a Toronto based global medical technology company that develops solutions to enhance patient information and improve the process...
Synaptive Medical Partners with Panaxium to Bring Real-Time Intelligent High-Resolution Cortical Mapping to Neurosurgical OR
October 11, 2022 11:22 ET
|
Synaptive Medical
TORONTO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Synaptive Medical Inc., a leader in surgical planning, navigation, and robotic visualization technologies, today announced a joint-development partnership...
Synaptive Medical Inc., Launches Dynamic Free Water Correction Feature to Enhance Planning and Navigation Technology
October 06, 2022 10:17 ET
|
Synaptive Medical
TORONTO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Synaptive Medical Inc., a leader in automated brain mapping and enriched patient data, announced the launch of Reveal today, a powerful new feature for its...
Synaptive Medical Appoints Mark Hanrahan as Chief Financial Officer
May 25, 2021 10:17 ET
|
Synaptive Medical
TORONTO, May 25, 2021 (GLOBE NEWSWIRE) -- Synaptive Medical, a leader in MRI and surgical robotics, has announced the appointment of Mark Hanrahan as Chief Financial Officer. “We are excited to...